CSRxP: Study Demonstrates Big Pharma Must Be Held Accountable in Part D Reform
Report Finds Significant Catastrophic Liability for Drug Makers Benefits… Read More
Report Finds Significant Catastrophic Liability for Drug Makers Benefits… Read More
Washington, D.C. – The U.S. Senate Special Committee on Aging held its third… Read More
Current Trade Agreement Could Hamper Generic and Biosimilar Competition… Read More
Greater List Price Transparency Will Help Crack Down on Big Pharma’s… Read More
Drug Makers Intensify Blame Game While Seeking to Avoid Accountability… Read More
Poll Finds U.S. Adults Blame Drug Makers for Rising Prices, Oppose… Read More
Bipartisan CREATES, FAIR Drug Pricing and REMEDY Acts Will Deliver Relief for… Read More
Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) today… Read More
NGA’s “2019 Principles for Federal Action to Address Health Care Costs”… Read More
Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released… Read More
Washington, D.C. – The U.S. House Energy & Commerce Subcommittee on… Read More
House Energy & Commerce Subcommittee Takes Up Transparency Bills Tuesday… Read More